For me it's Abbott Labs, with their work in the continuous glucose monitor segment. There is good moat and good applications (hospital use, other countries, Medicare may eventually cover non insulin using diabetes patients, ketone sensors, etc). IMO they are good value right now and they are a dividend aristocrat with growing dividend. I have about 45k invested.
Leave a Reply